blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2261216

EP2261216 - Pyrazoles as glucokinase activators [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.11.2012
Database last updated on 01.01.2025
Most recent event   Tooltip02.11.2012Application deemed to be withdrawnpublished on 05.12.2012  [2012/49]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2010/50]
Inventor(s)01 / Berthel, Steven Joseph
16 Calais Road
Mendham Township, NJ 07945 / US
02 / Kester, Robert Francis
162 Forest Hill Road
West Orange, NJ 07052 / US
03 / Murphy, Douglas Eric
14822 Heather Glen Way
San Diego, CA 92128 / US
04 / Prins, Thomas Jay
4671 Torrey Circle, Apt. 303
San Diego, CA 92130 / US
05 / Ruebsam, Frank
4517 Copeland Avenue
San Diego, CA 92116 / US
06 / Sarabu, Ramakanth
3 Candlewick Drive
Towaco, NJ 07082 / US
07 / Tran, Chinh Viet
10790 Dabney Drive 2
San Diego, CA 92126 / US
08 / Vourloumis, Dionisios
Isavron 18
16345, Athens / GR
 [2010/50]
Representative(s)Klostermeyer-Rauber, Dörte
F. Hoffmann-La Roche AG Corporate Law Patents (CLP) Grenzacherstrasse 124
4070 Basel / CH
[2010/50]
Application number, filing date10175986.816.07.2007
[2010/50]
Priority number, dateUS20060832907P24.07.2006         Original published format: US 832907 P
US20070930819P18.05.2007         Original published format: US 930819 P
[2010/50]
Previously filed application, dateWO2007EP5731516.07.2007
[2010/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2261216
Date:15.12.2010
Language:EN
[2010/50]
Type: A3 Search report 
No.:EP2261216
Date:14.12.2011
Language:EN
[2011/50]
Search report(s)(Supplementary) European search report - dispatched on:EP15.11.2011
ClassificationIPC:C07D231/40, C07D405/12, C07D413/06, A61K31/341, A61K31/25, A61K31/415, A61K31/5377, A61P1/18
[2010/50]
CPC:
C07D231/40 (EP,KR,US); A61K31/415 (KR); A61K31/535 (KR);
A61K31/5377 (KR); A61P1/18 (EP); A61P3/00 (EP);
A61P3/10 (EP); A61P43/00 (EP); C07D405/12 (EP,KR,US);
C07D413/06 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/50]
TitleGerman:Pyrazole als Glucokinase Aktivierer[2010/50]
English:Pyrazoles as glucokinase activators[2010/50]
French:Pyrazoles comme activateurs de la glucokinase[2010/50]
Examination procedure14.06.2012Examination requested  [2012/31]
15.06.2012Application deemed to be withdrawn, date of legal effect  [2012/49]
23.07.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2012/49]
Parent application(s)   TooltipEP07787582.1  / EP2046755
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070787582) is  22.12.2010
Fees paidRenewal fee
10.01.2011Renewal fee patent year 03
22.12.2010Renewal fee patent year 04
16.07.2011Renewal fee patent year 05
31.07.2012Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]WO2004072031  (OSI PHARM INC [US], et al) [X] 1-5,7-13,20,31-39 * claims 24-30; compounds 19,106,111,123 * [I] 1-13,20,22,24,25,29,31-39;
 [I]WO2006016194  (PROSIDION LTD [GB], et al) [I] 1-13,20,22,24,25,29,31-39 * claims 13-19; compound 2 *;
 [I]WO2006016178  (PROSIDION LTD [GB], et al) [I] 1-13,20,22,24,25,29,31-39 * example 3; claims 18,19,21-26 *;
 [XP]WO2007051846  (PROSIDION LTD [GB], et al) [XP] 1,2,4,5,7-9,11-13,22,31-39 * claims 14-19; compound 6 *;
 [XP]WO2007051845  (PROSIDION LTD [GB], et al) [XP] 1,2,4,5,7-9,11-13,22,31-39* claims 13-18; compound 9 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.